A detailed history of Grey Street Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Grey Street Capital, LLC holds 14,866 shares of ABBV stock, worth $2.89 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
14,866
Previous 2,719 446.75%
Holding current value
$2.89 Million
Previous $421 Million 542.5%
% of portfolio
0.37%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$159.82 - $182.1 $1.94 Million - $2.21 Million
12,147 Added 446.75%
14,866 $2.71 Billion
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $49,536 - $55,789
-360 Reduced 11.69%
2,719 $421 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $5,477 - $6,340
-41 Reduced 1.31%
3,079 $459 Million
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $135,557 - $168,692
1,023 Added 48.78%
3,120 $420 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $303,247 - $349,234
2,097 New
2,097 $334 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.